Get Permission Shankar, Nalla, Shobhitha, Kumari, and Pawar: Variations in complete blood counts and cellular morphological alterations in blood smear of COVID-19 patients from a tertiary care center


Introduction

Coronaviruses (CoV) are a large family of viruses which can cause broad spectrum diseases ranging from mild flu to Middle East Respiratory Syndrome (MERS-CoV) and Severe Acute Respiratory Syndrome (SARS coV).1 Towards the end of the year 2019, a new disease called COVID 19, related to corona virus species emerged from the city of Wuhan located in China.2 It was first observed in a group of patients who developed fever, cough and shortness of breath.1 The causative virus, severe acute respiratory syndrome coronavirus 2 (SARS- CoV-2) is capable of human- to- human transmission. This disease had further spread rapidly to other localities of the country (China) then worldwide3 giving rise to a pandemic in a few months causing about two million deaths.2 In addition to the archetypal respiratory symptoms, COVID 19 affects other organs as well, as shown by several other studies.3

The primary routes of SARSCoV-2 transmission is either through respiratory droplets or direct contact. Approximately about 80% of SARS-CoV-2 infections are mild, having flu-like symptoms with few cases being asymptomatic. About 15% of cases evolve into severe disease characterised by pneumonia and dyspnea. A meagre percentage of SARS-CoV-2-infected individuals require intensive care support as they experience acute respiratory distress syndrome (ARDS), septic shock eventually leading to multi-organ failure.4

Few of the studies have shown that the pathogenesis is brought about by penetration of virus into the host cell by interacting with the angiotensin-converting enzyme 2 (ACE2), a monocarboxypeptidase present on the cell surface of the epithelial cells of the respiratory tract and capillary endothelial cells.5

Imaging modalities and laboratory tests have shown certain abnormalities in COVID 19 patients. Lymphopenia and neutrophilia were the first reported laboratory findings in complete blood count analysis. A growing body of evidence suggests that the changes in the blood parameters are dynamic and it varies in patients according to the stage of disease.6

Assessment of blood cell morphology in peripheral blood film is a potent tool to evaluate patients’ blood samples with abnormalities in their blood counts. Unexplained cytopenia, suspected hematologic diseases, patients with suspected organ failure, infections and sepsis are the other few conditions which behooves blood smear examination.2 The major morphological alterations found in COVID 19 patients include atypical, reactive, and large granular lymphocytes (LGL), smudge cells, myeloid left shift, giant platelets, anisocytosis and poikilocytosis such as schistocytes has been described in literature.7, 8, 9, 10, 11 Alteration in lymphocyte count and the morphology are usually associated with other viral infections. But coronavirus appears to have a trilineage involvement of hematopoietic cells.12

In this study we aim to evaluate the alterations in the morphological details of the formed elements in peripheral blood film and the quantitative analysis of complete blood count in patients diagnosed with COVID 19 infection in our tertiary care centre.

Materials and Methods

It was an observational study which was carried out in a tertiary care center. The study was conducted from August 2021 to October 2021. The study population included patients who got admitted in the COVID 19 ICU and ward after being diagnosed as COVID 19 positive via Rapid antigen test or a real-time reverse transcription–polymerase chain reaction (RTPCR). A total of 96 cases were included in the study.

Inclusion criteria

All the blood samples of patients tested positive for COVID 19 (by either of the method) that was sent for complete blood counts and peripheral smear examination to the department of Hematopathology.

Exclusion criteria

The samples which couldn’t be analysed i.e, hemolysed samples or clotted samples.

Study tools

All medical records of the COVID 19 patients managed in ICU and ward.

Data collection

Clinical data of the patients were collected from the ward, medical records section and electronic hospital health records. For all the subjects included in the study, only the baseline values of complete blood count and peripheral smear reports were analysed.

Processing of blood samples

The blood samples (of subjects included in the study) from the COVID ICU and COVID ward was received in the hematopathology laboratory. The received blood samples were run in Beckman coulter-Coulter LH 780 Hematology Analyzer. Automatic counts of all samples were processed, analysed and documented. The values and changes in CBC parameters and its derived parameters were evaluated using the laboratory biological reference interval (Table 1).

Table 1

Biological reference interval

S. No

Parameter

Normal reference range

Inference

1.

Hemoglobin (Hb)

12 – 15 g/dl in females

<12 g/dl – Anemia

13 – 17 g/dl in males

<13 g/dl – Anemia

2.

Total WBC count

4 – 10 x10^3 /µl

< 4 x10^3 /µl – leucopenia

>10 x10^3 /µl – leukocytosis

3.

Platelets

150-450x10^3 /µl

<150 x10^3 /µl – thrombocytopenia

>450 x10^3 /µl – thrombocytosis

4.

Mean corpuscular Volume(MCV)

83-101 fL

<80 fL – microcytic picture

>101 – macrocytic picture

5.

Differential Leukocyte count

Cells

DC

AC

a) Neutrophils

40%-80%

2000-7000/cu.mm

Absolute count of <2000/cu.mm – neutropenia

Absolute count of >7000/cu.mm – neutrophilia

b) Lymphocytes

20%-40%

1000-3000/cu.mm

Absolute count of <1000/cu.mm – lymphopenia

Absolute count of >3000/cu.mm - lymphocytosis

c) Monocytes

2%-10%

200-1000/cu.mm

Absolute count of >1000/cu.mm - monocytosis

d) Eosinophils

0-6%

20-600/cu.mm

Absolute count of >600/cu.mm - eosinophilia

e) Basophils

0-1%

20-100/cu.mm

Absolute count of >100/cu.mm - basophilia

[i] DC – Differential count, AC – Absolute count

Blood smear preparation

Venous samples of COVID 19 patients were collected in EDTA vacutainers following which peripheral blood smears were made. A drop of blood was placed on a clean glass slide at one centimeter distance from one end. The drop of blood was spread quickly with a spreader at an angle of 30 degrees. The slides were air dried and were stained with Leishman stain for two minutes. After two minutes, buffer water of about twice the volume of stain used was added and left for about 8 minutes after which the slides were washed under slow flowing tap water. The stained slides were placed upright on a rack to dry.

Peripheral smear analysis

The slides were scanned at scanner view. One hundred leukocyte counts were performed at 100X magnification on each peripheral blood smear by the reporting pathologists. The differential counts were documented in percentage. The red blood cell morphology was studied at 100x magnification and the morphological data was documented for each case included in the study.

Ethical committee approval has been obtained from institutional human ethics committee.

Statistical data analysis

Data was entered into MS Excel 2007 version. Following this, the data was analyzed using SPSS version 20. Quantitative data were presented as mean and Standard deviation. Qualitative categorical variables were expressed as numbers and percentages.

Results

The total number of cases studied were 96. The mean age was 49.4 with a standard deviation of 16.8. Males constituted about 67.7% and females were 32.3% with a male to female ratio of 2.09.

Quantitative changes

The hemoglobin was normal in majority of the cases which was seen in 64 (66.7%) cases. Three out of these 64 cases (4.7%) showed macrocytic blood picture with an MCV value of above 101.

The total WBC counts were increased (leukocytosis) in majority of the cases which was observed in 75(78.12%) cases. In the total 96 cases studied, absolute lymphopenia was seen in 5 (5.2%)cases, relative lymphopenia was seen in 82 (85.5%).

Majority of the patients, 74 (77.1%) had platelets within normal limits (Table 2).

Table 2

Characteristics of blood parameters in COVID-19 patients

Variables

Number of cases [total (n)=96]

Percentage of cases

Hemoglobin

Within normal limits

64

66.7%

Low (anemia)

32

33.3%

Total WBC counts

Within normal limits

20

20.84%

Increased (leukocytosis)

75

78.12%

Decreased (leucopenia)

1

1.04%

Differential WBC counts

Normal distribution

8

8.3%

Neutrophilia [includes absolute and relative neutrophilia]

83

86.4%

Absolute Lymphopenia

5

5.3%

Platelets

Within normal limits

74

77.1%

Increased in count (thrombocytosis)

7

7.3%

Decreased in count (Thrombocytopenia)

15

15.6%

Morphological changes

Hemoglobin was low in 32 (33.3%) cases, which was categorized as anemia and further classified according to the morphology seen in peripheral smear in conjuction with the MCV values on coulter reading into, microcytic anemia and normocytic anemia (Table 3).

Table 3

Morphological type of Anemias observed in COVID-19 patients

Type of anemia

Number of cases with anemia [total (n)=32]

Percentage of cases

Normocytic anemia

22

68.7%

Microcytic hypochromic anemia

10

31.3%

Out of the 75 cases with leukocytosis, Neutrophilic leukocytosis was seen in 71 (94.7%) cases. Shift to left of neutrophil series along with presence of toxic granules (Figure 1) in the cytoplasm of neutrophils were seen in 70 (72.9%) of the cases. Lymphocytes with reactive changes (Figure 2) were seen in 20.83% of cases as explained in the table. One case had a leukoerythroblastic blood picture in our study (Table 4).

Table 4

Morphological abnormalities of formed elements in peripheral blood smear of COVID 19 patients

Leukocyte

Morphological change

Number of cases

Total (n)=96

Percentage of cases

Neutrophils

Toxic granules

60

62.5%

Toxic granules and Cytoplasmic vacuolation

10

10.41%

Hypolobated neutrophils

3

3.12%

Lymphocytes

Reactive lymphocytes

Total=20

Total % = 20.83%

a) Plasmacytoid

11

11.45%

b) Monocytoid

7

7.3%

c) Turk cell

2

2.08%

d) Large granular lymphocytes

1

1.04%

RBC and WBC

Leukoerythroblastic picture

1

1.04%

Platelets

Giant platelets

4

4.16%

Figure 1

Morphology of neutrophils in blood smear of COVID 19 patients:(a) Hypolobated neutrophils; (b) Shift to left of neutrophils showing metamyelocyte, band form and segmented forms (c) Segmented neutrophils with cytoplasmic vacuolations and toxic granules. [X1000, Leishman stain]

https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/ecf42828-f76c-4b81-86c3-d1f1c75d12f9/image/173ca5f9-98d5-42a6-843f-35556e24169c-uimage.png

Figure 2

Morphology of lymphocytes in blood smear of COVID 19 patients: (a): Monocytoid morphology of reactive lymphocyte; (b): Reactive lymphocytes and neutrophils; (c): Plasmacytoid morphology of reactive lymphocyte. [X1000, Leishman stain]

https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/ecf42828-f76c-4b81-86c3-d1f1c75d12f9/image/19998744-b761-4a36-9891-3edf81db9e99-uimage.png

Discussion

COVID-19 has rapidly spread and evolved into a pandemic after it has been identified in the year 2019 at Wuhan China.8 The spike protein present on the surface of the virus viral plays a key role in host attachment and penetration. SARS-CoV-2 infection remarkably affects the respiratory system. But it has been found that it may also involve the hematopoietic system and has a role in homeostasis.13 Previous studies elucidate that TLC is normal or slightly low in the incubation period of disease ranging from 1 to 14 days. However, after 7 to 14 days of illness, the course of illness is governed by inflammatory mediators and cytokines leading to a cytokine storm.14 The hematopoietic system actions a thoughtful character in the notable hyperinflammation, mainly in severely ill patients.15

The alterations in the laboratory parameters such as hematologic abnormalities have been reported in COVID-19 patients. The association of these alterations with early diagnosis, disease prognosis and severity has been discussed time and again in the literature. Complete blood count analysis is a basic, easy and cost effective haematological test that is customarily being performed which plays an imperative role in early diagnosis of the disease.13

Fibrinogen, prothrombin time (PT), activated partial thromboplastin time (APTT) and D dimer tests are the other additional tests performed for the diagnosis of COVID 19.16 Prevailing haematological deviance seen in COVID-19 are: anaemia, leucocytosis or leucopenia, neu­trophilia, low eosinophil count or eosinophilia, thrombocytopenia, and rarely thrombocytosis.17

In the present study, 33.3% of the cases showed anemia, whereas hemoglobin within normal limits were observed in 66.7% of the cases. Peripheral smear examination of these patients showed normocytic and normochromic blood picture. In a study done by Nath D et al,18 similar finding was observed.

Elevated neutrophil count is seen in severe COVID-19 patients19 which implies association of the myeloid series in COVID 19, which is unapparent in other viral infections.12 In our study, the most characteristic WBC finding was neutrophilic leukocytosis in majority of the cases and leucopenia was seen in only one case.

Neutrophils with toxic granulation was seen in 72.9% of the cases which was similar to the study done by Singh A et al20 and Kannan G et al.21 Shift to left of myeloid series was seen in our study which was similar to a study done by Zini G et al,22 Kaur G et al5 and khandelwal A et al.23 In all these studies, the smears of patients with neutrophilia showed shift to left of neutrophil series with presence of band forms, metamyelocytes, and myelocytes. Cytoplasmic vacuolations were appreciated in cases which had critical clinical outcome. Kaur G et al5 has described similar findings in their study.

Reduction in the nuclear lobularity were also seen in a few (3.12% ) cases in our study and that was described by Nazarullah et al8 and Zini et al22 in their respective studies. Previous literatures have shown that these findings may be attributed to the fact that there is direct infection of the hematopoietic stem cells and the progenitor cells. Apart from the action of inflammatory cytokines, in the setting of infection, there can be a possible change in the bone marrow microenvironment.22, 24

Neutrophilia is a feature that correlates with the hyper-inflammatory state and cytokine storm, which is pathognomonic of COVID-19. With the advancement of the disease stage, there has been a quantitative increase in the circulating neutrophils. Gradual increase in neutrophil count is seen with the advancement of COVID 19. Neutrophilia can thus be considered as a marker of poor outcome following severe respiratory disease.25

In contrast to most of the literature on COVID 19, our study showed minimal number of cases (5.3%) with absolute lymphopenia, which is comparable to a study done by Nazarulla A et al,8 where absolute lymphopenia was seen only in two cases. A subset of total cases showed presence of reactive lymphocytes. Predominant type of reactive lymphocyte in this study showed plasmacytoid appearance seen in 11.45% of the cases. Monocytoid appearance of reactive lymphocytes were appreciated in 7.3% of the cases. Fan BE et al17 has done a study in which he describes about lymphopenia with reactive lymphocytes. In his study few of the cases showed monocytoid and or lympho-plasmacytoid appearance of reactive lymphocytes. The B-lymphocytes become activated to form lympho-plasmacytoid type of reactive lymphocytes with a distinct morphology and also forms immunoglobulin-secreting plasma cells during a viral infection. The mechanism behind peripheral blood lymphopenia remains unclear. It could possibly be justified due to mobilization of the cells to the infected site, virus induced destruction of T cells,26 direct viral toxicity and cytokine-induced lymphopenia.27 Large granular lymphocytes were seen in just one case in our study comparable to a study done by Singh et al.20

Leukoerythroblastic reaction, an exceptional finding have also been described in this study in 1% of the cases. Mitra et al7 and Pezeshki A et al,2 have described similar features in their respective studies. Platelet count was normal in majority of the cases in our study which constituted about 77.1% similar to Kaur G et al5 study.

Thrombocytopenia was observed in 15.6% cases similar to studies done by Sundari A et al28 and Dudve S S et al.29 However, the percentage of cases with thrombocytopenia was variable. Lippi et al30 in his study has shown correlation of low platelet count with increased severity of the disease and association with augmented mortality. Three mechanisms of a cascade can be assumed to explain thrombocytopenia in SARSCoV- 2 infections: 1) Infection of the marrow by virus thereby inhibiting platelet synthesis; 2) Destructive mechanism of the immune system on platelets; 3) Further consumption of platelets due to formation of platelet aggregate and microthrombi in the lungs.25

Platelet synthesis will be reduced due to the role played by the viruses in their interaction with the megakaryocytes in the bone marrow.31 There are specific receptors upon which SARS-CoV-2 acts and inhibits the bone marrow hematopoiesis there by depressing the formation of platelets resulting in peripheral thrombocytopenia.32

The morphological abnormality observed in platelets were giant platelets seen in 4.16% in our study, similar to studies done by Pezeshki A et al,2 Mitra A et al,7 Sadigh S et al,11 Marchi G et al.33

Limitation of the Study

The study was performed for a short duration and with relatively small sample size. Only the baseline values were analysed in the study and no conjuction with biochemical tests were made. A study with longer duration with more number of study subjects and samples taken during different disease stages (according to severity) would represent a better clinico-pathological correlation.

Conclusion

Analysis of the parameters of complete blood counts and peripheral blood smear examination are the basic tests done for diagnosis of any clinical condition. In COVID 19 patients, one of the investigative findings include alterations in CBC values and the morphology of cellular elements in the peripheral blood smear. Toxic granules and cytoplasmic vacuolations in neutrophils may indicate ongoing sepsis in COVID 19 patients. This would predict prognosis earlier and can aid the clinicians in timely management. Follow up evaluation of CBC and blood smear of COVID 19 patients during different disease stages would help in early detection of complications, thus reducing the mortality rate. However, evaluation of other parameters along with CBC and peripheral smear would be of paramount importance for diagnosis of the disease.

Source of Funding

None.

Conflict of Interest

None.

References

1 

I Berber O Cagasar A Sarici KN Berber I Aydogdu O Ulutas Peripheral Blood Smear Findings of COVID-19 Patients Provide İnformation about the Severity of the Disease and the Duration of Hospital StayMediterr J Hematol Infect Dis2021131e202100910.4084/MJHID.2021.009

2 

A Pezeshki A Vaezi P Nematollahi Blood cell morphology and COVID-19 clinical course, severity, and outcomeJ Hematop20211432218

3 

MZ Tay CM Poh L Rénia PA Macary LF Ng The trinity of COVID-19: immunity, inflammation and interventionNat Rev Immunol202020636374

4 

AAF de Vries Renin-angiotensin system inhibition in COVID-19 patientsNeth Heart J2020287-8396405

5 

G Kaur F Sandeep O Olayinka G Gupta Morphologic Changes in Circulating Blood Cells of COVID-19 PatientsCureus2021132e1341610.7759/cureus.13416

6 

H Esakandari M Nabi-Afjadi J Fakkari-Afjadi N Farahmandian S M Miresmaeili E Bahreini A comprehensive review of COVID-19 characteristicsBiol Proced Online2020221910.1186/s12575-020-00128-2

7 

A Mitra DM Dwyre M Schivo GR Thompson SH Cohen N Ku Leukoerythroblastic reaction in a patient with COVID-19 infectionAm J Hematol20209589991000

8 

A Nazarullah C Liang A Villarreal RA Higgins DD Mais Peripheral blood examination findings in SARS-CoV-2 infectionAm J Clin Pathol2020154331929

9 

D Gérard S Henry B Thomas SARS-CoV-2: a new aetiology for atypical lymphocytesBr J Haematol2020189584510.1111/bjh.16730

10 

E Schapkaitz T DeJager B Levy The characteristic peripheral blood morphological features of hospitalized patients infected with COVID-19Int J Lab Hematol20214331304

11 

S Sadigh LR Massoth BB Christensen JA Stefely J Keefe AR Sohani Peripheral blood morphologic findings in patients with COVID-19Int J Lab Hematol202042624851

12 

AR Bhalchandra S Rai M Gunjiganvi P Mishra A Nath RK Singh Morphological Changes in Peripheral Blood in COVID-19 InfectionInt Arch Bio Med Clin Res20217416

13 

S Gajendra Spectrum of hematological changes in COVID-19Am J Blood Res20221214353

14 

P Mishra S Agarwal P Patni S Pathak M Kaur N Rehman Peripheral blood morphology and hemogram in COVID-19 patients correlates with disease severity: Insights from a Tertiary Care CenterMed J DY Patil Vidyapeeth202215Suppl 227885

15 

HM Tabriz E Nazar F Jazayeri AE Javadi Hematologic Presentations of COVID-19 Can be Misinterpreted as Acute Myeloid LeukemiaAsian Pac J Cancer Biol2021632313

16 

G Agarwal S Gupta N Singh S Mittal A Verma MS Bindra Changes in morphology of white blood cells on peripheral smear in COVID-19 infectionInt J Res Med Sci20219823936

17 

BE Fan VCL Chong SSW Chan GH Lim KGE Lim GB Tan Hematologic parameters in patients with COVID-19 infectionAm J Hematol20209561314

18 

D Nath U Madan S Singh N Tiwari J Madan R Agrawal CBC parameters and morphological alterations in peripheral blood cells in COVID-19 patients: Their significance and correlation with clinical courseInt. J.Health Clin.Res202031095108

19 

LHA Cavalcante-Silva DCM Carvalho ÉA Lima JGFM Galvão JSDF Silva JM Sales-Neto Neutrophils and COVID-19: The road so farInt Immunopharmacol202190107233

20 

A Singh N Sood V Narang A Goyal Morphology of COVID 19 affected cells in peripheral blood filmBMJ Case Rep2020135e23611710.1136/bcr-2020-236117

21 

G Kannan M Soni Leukocyte morphological changes in COVID&#8209;19, a peripheral smear study and analysis at a Tertiary Health Care Centre in IndiaApollo Med202118315861

22 

G Zini S Bellesi F Ramundo G Onofrio Morphological anomalies of circulating blood cells in COVID-19Am J Hematol20209578702

23 

A Khandelwal R Shrivastava S Pawar A Pandey Morphology of WBCs on Peripheral Blood Smear of COVID 19 Positive PatientsAnnals of Pathol Lab Med20211182437

24 

F Lüke E Orsó J Kirsten H Poeck M Grube D Wolff Coronavirus disease 2019 induces multi-lineage, morphologic changes in peripheral blood cellsEJHaem20201137683

25 

M Palladino Complete blood count alterations in COVID-19 patients: A narrative reviewBiochem Med (Zagreb)202131303050110.11613/BM.2021.030501

26 

SS Ahmed DA Mohammed AA Mohammed Hematological and Morphological Changes in the Peripheral Blood Smear of Patients with COVID-19J Kermanshah Univ Med Sci2021252e110758

27 

E Terpos I Ntanasis-Stathopoulos I Elalamy E Kastritis TN Sergentanis M Politou Hematological findings and complications of COVID-19Am J Hematol202095783447

28 

AA Sundari R Shivapriya TM Karthikeyan V Venkatesh Morphological Changes in Blood Cells as Indicators for Disease Progression in COVID-19J Appl Hematol202314417

29 

SS Dudve N Banseria AK Pandey PK Jain Evaluation of Bone Marrow Findings of COVID-19 by Minimally Invasive Autopsies: A Single Tertiary Care Centre Experience from IndiaEur J Mol Clin Med20229697986

30 

G Lippi M Plebani BM Henry Thrombocytopenia is associated with severe corona virus disease 2019 (COVID-19) infections: a meta-analysisClin Chim Acta20205061458

31 

M Seyoum B Enawgaw M Melku Human blood platelets and viruses: defense mechanism and role in the removal of viral pathogensThromb J2018161610.1186/s12959-018-0170-8

32 

J Ropa S Cooper ML Capitano WV Hof HE Broxmeyer Human Hematopoietic Stem, Progenitor, and Immune Cells Respond Ex Vivo to SARS-CoV-2 Spike ProteinStem Cell Rev Rep202117125365

33 

G Marchi C Bozzini L Bertolone F Dima F Busti A Castagna Red Blood Cell Morphologic Abnormalities in Patients Hospitalized for COVID-19Front. Physiol20221393201310.3389/fphys.2022.932013



jats-html.xsl


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

  • Article highlights
  • Article tables
  • Article images

Article History

Received : 08-06-2023

Accepted : 17-08-2023


View Article

PDF File   Full Text Article


Copyright permission

Get article permission for commercial use

Downlaod

PDF File   XML File   ePub File


Digital Object Identifier (DOI)

Article DOI

https://doi.org/10.18231/j.ijpo.2023.057


Article Metrics






Article Access statistics

Viewed: 831

PDF Downloaded: 144



Medical Abbreviation List